Cardiorenal Medicine, 2025 Biomarkers associated with worsening renal function and progression in chronic kidney disease among patients hospitalized for acute heart failure Ohlsson M., Molvin J., Holm Isholth H. et al. Olink Target 96CVDNephrologyPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2025 Mediating Role of the ANGPTL3/TFPI Protein Ratio in Regulating T-Cell Surface Glycoprotein CD5 Levels on Knee Osteoarthritis (KOA): A Mendelian Randomization Study Li Y., Liao X., Yu X. et al. Olink Target 96Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Journal of Proteome Research, 2025 Plasma Proteomics-Based Identification of Novel Predictive and Diagnostic Inflammatory Biomarkers for Diabetic Foot Feng Y., Jiang B., Luo Q. et al. Olink Target 96Metabolic DiseasesPatient StratificationPlasma | | | | |
Therapeutic Advances in Endocrinology and Metabolism, 2025 Multi-omics investigation of prospective therapeutic targets for type 1 diabetes Zhang Y., Qiao Q., Chen B. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma | | | | |
Molecular Neurobiology, 2025 Identifying Immune Response Protein Biomarkers in Parkinson’s-Related Cognitive Impairment and Depression Su Q., Lu T., Xu Y. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Journal of Inflammation Research, 2025 Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies Zhang Y., Hu W., Li T. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Cardiovascular Research, 2025 Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study—differences and similarities Fall T., Gummesson A., Hammar U. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2025 Unraveling the COVID-19 Severity Hubs and Interplays in Inflammatory-Related RNA–Protein Networks Park H., Wang Q., Hasegawa T. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyBlood | | | | |
The Journal of Dermatology, 2025 Immunoproteomic Response to IL‐17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling Jeng Y., Liao Y., Hong Y. et al. Olink Target 96Dermatological DiseasesPathophysiologyPlasma | | | | |
Journal of Cardiology, 2025 Causal relationship between circulating inflammatory proteins and atherosclerosis: a bidirectional Mendelian randomization study and meta-analysis Xu B., Xu Q., Wang Y. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Molecular Neurobiology, 2025 Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis Xu Y., Xiong J., Wu Y. et al. Olink Explore 3072/384NeurologyUrologyPathophysiologyPlasma | | | | |
The Journal of Nutrition, 2025 Metabolomic and Proteomic Signatures of Ultra-processed Foods Are Positively Associated with Adverse Liver Outcomes Zhao L., Chen Y., Clay-Gilmour A. et al. Olink Explore 3072/384Metabolic DiseasesNutritional SciencePathophysiologyPlasma | | | | |
Journal of the American College of Cardiology, 2025 Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure Ferreira J., Anker S., Butler J. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
BMC Pregnancy and Childbirth, 2025 Sleeping for two: a cross-sectional study on associations between objectively measured sleep during early to mid-pregnancy and maternal and fetal outcomes and inflammatory biomarker profiles Macdonald C., Pitsillos T., Wikström A. et al. Olink Target 96ObstetricsPathophysiologyPlasma | | | | |
International Immunopharmacology, 2025 The interplay between systemic inflammation and myopia: A bidirectional Mendelian randomization and experimental validation study Huang Z., Zhou J., Liu S. et al. Olink Target 96Olink Explore 3072/384OphthalmologyPathophysiologyPlasma | | | | |
Journal of Advanced Research, 2025 Plasma proteomics identify novel biomarkers and dynamic patterns of biological aging Ma L., Liu W., He Y. et al. Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
Discover Oncology, 2025 Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer Cao J., Chen S., Wang J. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Nature Immunology, 2025 Identification of soluble biomarkers that associate with distinct manifestations of long COVID Gao Y., Cai C., Adamo S. et al. Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma | | | | |
Investigational New Drugs, 2025 Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors Cohen R., Jimeno A., Hreno J. et al. Olink Target 96OncologyImmunotherapyPathophysiology | | | | |
Stroke, 2025 Proteome-Wide Genetic Study in East Asians and Europeans Identified Multiple Therapeutic Targets for Ischemic Stroke Yao P., Mazidi M., Pozarickij A. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |